An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)
Clinical trial NCT03114228 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03114228
- Sponsor
- Novartis Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.